Cargando…
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
Autores principales: | Praktiknjo, Michael, Witt, Antonia, Schepis, Filippo, Garcia-Pagan, Juan Carlos, Merli, Manuela, Trebicka, Jonel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411234/ https://www.ncbi.nlm.nih.gov/pubmed/34505036 http://dx.doi.org/10.1016/j.jhepr.2021.100349 |
Ejemplares similares
-
The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites
por: Mansour, Sohaïb, et al.
Publicado: (2021) -
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation
por: Praktiknjo, Michael, et al.
Publicado: (2021) -
Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation
por: Liu, Jiacheng, et al.
Publicado: (2021) -
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm
por: Guttmann, Oliver P., et al.
Publicado: (2016) -
Novel 7-mm-diameter double bare metal stent for endoscopic side-by-side stent placement in malignant hilar biliary obstruction
por: Asai, Satoshi, et al.
Publicado: (2020)